1. Home
  2. PTGX vs DOCN Comparison

PTGX vs DOCN Comparison

Compare PTGX & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • DOCN
  • Stock Information
  • Founded
  • PTGX 2006
  • DOCN 2011
  • Country
  • PTGX United States
  • DOCN United States
  • Employees
  • PTGX N/A
  • DOCN N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • DOCN Retail: Computer Software & Peripheral Equipment
  • Sector
  • PTGX Health Care
  • DOCN Technology
  • Exchange
  • PTGX Nasdaq
  • DOCN Nasdaq
  • Market Cap
  • PTGX 2.9B
  • DOCN 2.5B
  • IPO Year
  • PTGX 2016
  • DOCN 2021
  • Fundamental
  • Price
  • PTGX $47.47
  • DOCN $28.30
  • Analyst Decision
  • PTGX Strong Buy
  • DOCN Buy
  • Analyst Count
  • PTGX 8
  • DOCN 14
  • Target Price
  • PTGX $66.50
  • DOCN $40.62
  • AVG Volume (30 Days)
  • PTGX 789.1K
  • DOCN 1.7M
  • Earning Date
  • PTGX 05-06-2025
  • DOCN 05-06-2025
  • Dividend Yield
  • PTGX N/A
  • DOCN N/A
  • EPS Growth
  • PTGX N/A
  • DOCN 119.67
  • EPS
  • PTGX 0.86
  • DOCN 1.14
  • Revenue
  • PTGX $207,801,000.00
  • DOCN $806,588,000.00
  • Revenue This Year
  • PTGX N/A
  • DOCN $15.18
  • Revenue Next Year
  • PTGX $50.30
  • DOCN $13.89
  • P/E Ratio
  • PTGX $55.04
  • DOCN $24.93
  • Revenue Growth
  • PTGX N/A
  • DOCN 13.21
  • 52 Week Low
  • PTGX $27.00
  • DOCN $25.45
  • 52 Week High
  • PTGX $60.60
  • DOCN $47.02
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 58.60
  • DOCN 42.90
  • Support Level
  • PTGX $45.43
  • DOCN $27.98
  • Resistance Level
  • PTGX $46.80
  • DOCN $28.95
  • Average True Range (ATR)
  • PTGX 1.54
  • DOCN 1.00
  • MACD
  • PTGX 0.34
  • DOCN -0.16
  • Stochastic Oscillator
  • PTGX 94.26
  • DOCN 15.59

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About DOCN DigitalOcean Holdings Inc.

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.

Share on Social Networks: